Century Therapeutics Inc (IPSC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 55,307 | 64,439 | 86,832 | 84,265 | 111,350 |
| Marketable Securities | 114,198 | 91,958 | 164,637 | 231,233 | 244,509 |
| Other current assets | 0 | 0 | 0 | 220 | 346 |
| TOTAL | $173,703 | $161,280 | $255,934 | $319,721 | $361,641 |
| Non-Current Assets | |||||
| PPE Net | 81,993 | 83,771 | 85,842 | 82,785 | 77,938 |
| Investments And Advances | 115,325 | 145,136 | 84,266 | 53,114 | 40,705 |
| Other Non-Current Assets | 26,530 | 26,972 | 30,186 | 30,924 | 31,467 |
| TOTAL | $223,848 | $255,879 | $200,294 | $166,823 | $150,110 |
| Total Assets | $397,551 | $417,159 | $456,228 | $486,544 | $511,751 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 705 | 744 | 11,178 | 7,368 | 4,896 |
| Accounts payable and accrued liabilities | 5,927 | 3,625 | 3,475 | 5,454 | 5,685 |
| Accrued Expenses | 9,932 | 7,856 | 6,531 | 9,841 | 8,755 |
| TOTAL | $20,435 | $19,161 | $27,684 | $29,817 | $26,907 |
| Non-Current Liabilities | |||||
| Long Term Debt | 201 | 361 | 433 | 4,457 | 7,107 |
| Deferred Revenues | 3,871 | 6,936 | 6,500 | 7,154 | 7,571 |
| Other Non-Current Liabilities | 45,535 | 40,833 | 41,168 | 38,698 | 36,594 |
| TOTAL | $157,886 | $150,427 | $151,369 | $153,989 | $154,639 |
| Total Liabilities | $178,321 | $169,588 | $179,053 | $183,806 | $181,546 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 59,835 | 59,765 | 59,581 | 59,171 | 58,974 |
| Common Shares | 6 | 6 | 6 | 6 | 6 |
| Retained earnings | -616,373 | -583,652 | -550,362 | -519,098 | -487,416 |
| Other shareholders' equity | -1,304 | -1,208 | -1,275 | -2,462 | -3,604 |
| TOTAL | $219,230 | $247,571 | $277,175 | $302,738 | $330,205 |
| Total Liabilities And Equity | $397,551 | $417,159 | $456,228 | $486,544 | $511,751 |